scholarly article | Q13442814 |
P2093 | author name string | Katsuaki Sato | |
Masanori Baba | |||
Naohide Yamashita | |||
Takami Matsuyama | |||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | dendritic cell | Q506253 |
P304 | page(s) | 3581-3589 | |
P577 | publication date | 2003-01-02 | |
P1433 | published in | Blood | Q885070 |
P1476 | title | Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells | |
P478 | volume | 101 |
Q53638883 | 1alpha,25-Dihydroxyvitamin D3 downmodulates the functional differentiation of Th1 cytokine-conditioned bone marrow-derived dendritic cells beneficial for cytotoxic T lymphocyte generation. |
Q42143137 | A short protocol using dexamethasone and monophosphoryl lipid A generates tolerogenic dendritic cells that display a potent migratory capacity to lymphoid chemokines. |
Q37914776 | Advancing islet transplantation: from engraftment to the immune response |
Q26768528 | Antibody Targeting of "Steady-State" Dendritic Cells Induces Tolerance Mediated by Regulatory T Cells |
Q24186713 | Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer) |
Q57689443 | Application of seminal plasma to female genital tract prior to embryo transfer in assisted reproductive technology cycles (IVF, ICSI and frozen embryo transfer) |
Q84749044 | Blockage of nerve growth factor modulates T cell responses and inhibits allergic inflammation in a mouse model of asthma |
Q37773291 | Blocking costimulatory pathways: prospects for inducing transplantation tolerance. |
Q35936484 | CD4+ Tregs and immune control |
Q36251271 | CD4+ regulatory cells as a potential immunotherapy |
Q35868629 | Can an immune-regulatory vaccine prevent HIV infection? |
Q34990554 | Characterization of regulatory dendritic cells that mitigate acute graft-versus-host disease in older mice following allogeneic bone marrow transplantation |
Q37627785 | Collagen scaffold microenvironments modulate cell lineage commitment for differentiation of bone marrow cells into regulatory dendritic cells |
Q36114240 | Cytokine-conditioned dendritic cells induce humoral tolerance to protein therapy in mice |
Q34503547 | DC expressing transgene Foxp3 are regulatory APC. |
Q35988802 | Dendritic cell-mediated T cell polarization |
Q38033163 | Dendritic cells a double-edge sword in autoimmune responses |
Q36425922 | Dendritic cells as promoters of transplant tolerance |
Q81122396 | Dendritic cells derived from TBP-2-deficient mice are defective in inducing T cell responses |
Q36272587 | Dendritic cells in allogeneic hematopoietic stem cell transplantation |
Q79967042 | Dendritic cells in cancer immunotherapy |
Q83062079 | Dendritic cells modification during sublingual immunotherapy in children with allergic symptoms to house dust mites |
Q43225468 | Dendritic cells treated with resveratrol during differentiation from monocytes gain substantial tolerogenic properties upon activation |
Q35620073 | Dendritic cells: emerging pharmacological targets of immunosuppressive drugs |
Q35583516 | Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction |
Q80801951 | Dexamethasone transforms lipopolysaccharide-stimulated human blood myeloid dendritic cells into myeloid dendritic cells that prime interleukin-10 production in T cells |
Q41754216 | Differential regulation of naïve and memory CD4+ T cells by alternatively activated dendritic cells |
Q42516076 | Differentiation of human dendritic cell subsets for immune tolerance induction |
Q37374961 | Diversity in the contribution of interleukin-10 to T-cell-mediated immune regulation. |
Q36585041 | Does our current understanding of the molecular basis of immune tolerance predict new therapies for autoimmune disease? |
Q98784876 | Donor myeloid derived suppressor cells (MDSCs) prolong allogeneic cardiac graft survival through programming of recipient myeloid cells in vivo |
Q36486882 | Emerging possibilities in the development and function of regulatory T cells |
Q50055705 | Evaluation of a Small Animal Irradiation System for Animal Experiments Using EBT3 Model GAFCHROMIC™ Film |
Q37773272 | Future therapeutics for the induction of peripheral immune tolerance in autoimmune disease and organ transplantation |
Q26779413 | Gene Expression Profiling of Human Monocyte-derived Dendritic Cells - Searching for Molecular Regulators of Tolerogenicity |
Q37555225 | Generation and characterization of regulatory dendritic cells derived from murine induced pluripotent stem cells |
Q35216458 | Generation and function of antigen-specific suppressor and regulatory T cells |
Q36586957 | Guarding the immune system: suppression of autoimmunity by CD4+CD25+ immunoregulatory T cells |
Q35605610 | Hepatocyte growth factor prevents lupus nephritis in a murine lupus model of chronic graft-versus-host disease |
Q34631825 | How tolerogenic dendritic cells induce regulatory T cells |
Q36559879 | Human monocytes undergo functional re-programming during differentiation to dendritic cell mediated by human extravillous trophoblasts |
Q81828648 | Human spleen contains different subsets of dendritic cells and regulatory T lymphocytes |
Q38078109 | Human tolerogenic DC-10: perspectives for clinical applications. |
Q51050539 | IL-10/TGF-beta-treated dendritic cells, pulsed with insulin, specifically reduce the response to insulin of CD4+ effector/memory T cells from type 1 diabetic individuals. |
Q33493421 | Immature and maturation-resistant human dendritic cells generated from bone marrow require two stimulations to induce T cell anergy in vitro |
Q35766216 | Immune regulation through mitochondrion-dependent dendritic cell death induced by T regulatory cells |
Q44126280 | Immunoregulatory function of PIR-A/B+ DCs in the inflammatory responses of dextran sodium sulfate-induced colitis. |
Q35882794 | Immunosuppressive exosomes: a new approach for treating arthritis |
Q37861025 | Immunotherapy with pluripotent stem cell-derived dendritic cells |
Q55004069 | Induction of Interleukin-10 Producing Dendritic Cells As a Tool to Suppress Allergen-Specific T Helper 2 Responses. |
Q52672772 | Induction of PIR-A/B+ DCs in the in vitro inflammatory condition and their immunoregulatory function. |
Q24678698 | Induction of antigen-specific regulatory T lymphocytes by human dendritic cells expressing the glucocorticoid-induced leucine zipper |
Q34339782 | Liaison between natural killer cells and dendritic cells in human gestation |
Q91695862 | Mesenchymal stem cells induce dendritic cell immune tolerance via paracrine hepatocyte growth factor to alleviate acute lung injury |
Q33825688 | Modulation of gene expression related to Toll-like receptor signaling in dendritic cells by poly(gamma-glutamic acid) nanoparticles |
Q40279818 | Murine dendritic cells that are resistant to maturation are unable to induce tolerance to allogeneic stem cells |
Q39614582 | PD-L1 blockade improves immune dysfunction of spleen dendritic cells and T-cells in zymosan-induced multiple organs dysfunction syndromes |
Q80643813 | Paired immunoglobin-like receptors A and B are new targets for inducing dendritic cells tolerance in mice |
Q36593312 | Physiologic regulation of central and peripheral T cell tolerance: lessons for therapeutic applications |
Q97519150 | Progress in Liver Transplant Tolerance and Tolerance-Inducing Cellular Therapies |
Q80790178 | Protective role of interleukin-10-producing regulatory dendritic cells against murine autoimmune gastritis |
Q36693973 | Regulation of dendritic cell differentiation by vasoactive intestinal peptide: therapeutic applications on autoimmunity and transplantation |
Q40049981 | Regulatory Dendritic Cells |
Q89228449 | Regulatory Dendritic Cells Induced by Mesenchymal Stem Cells Ameliorate Dextran Sodium Sulfate-Induced Chronic Colitis in Mice |
Q36563523 | Regulatory T cells in the periphery |
Q37302327 | Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment? |
Q26866216 | Regulatory dendritic cells for immunotherapy in immunologic diseases |
Q73153290 | Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse |
Q37140284 | Regulatory immune cells in kidney disease |
Q38224322 | Regulatory tone and mucosal immunity in asthma |
Q37348454 | Retinoic acid in the immune system |
Q42660401 | Role of biphasic changes in splenic dendritic cell activity in a mouse model of multiple organ dysfunction syndrome |
Q28742855 | SHIP-deficient dendritic cells, unlike wild type dendritic cells, suppress T cell proliferation via a nitric oxide-independent mechanism |
Q38088289 | Seminal fluid and the generation of regulatory T cells for embryo implantation. |
Q58816247 | Specific recruitment of CD4+CD25++ regulatory T cells into the allograft in heart transplant recipients |
Q61645726 | Splenic stroma drives mature dendritic cells to differentiate into regulatory dendritic cells |
Q37773293 | Suicide gene therapy for graft-versus-host disease. |
Q36059606 | TGF-beta combined with M-CSF and IL-4 induces generation of immune inhibitory cord blood dendritic cells capable of enhancing cytokine-induced ex vivo expansion of myeloid progenitors |
Q84474553 | Targeting myeloid regulatory cells in cancer by chemotherapeutic agents |
Q64063170 | The Pivotal Role of Regulatory T Cells in the Regulation of Innate Immune Cells |
Q37959968 | The dendritic cell-regulatory T lymphocyte crosstalk contributes to tumor-induced tolerance |
Q82385519 | The effect of azithromycin on the maturation and function of murine bone marrow-derived dendritic cells |
Q33498507 | The induction of APC with a distinct tolerogenic phenotype via contact-dependent STAT3 activation |
Q39613283 | Therapeutic potential of semi-mature dendritic cells for tolerance induction |
Q33463837 | Toll-like receptors, chemokine receptors and death receptor ligands responses in SARS coronavirus infected human monocyte derived dendritic cells. |
Q84371375 | Vaccination with collagen-pulsed dendritic cells prevents the onset and reduces the disease severity in the mouse model of spontaneous polychondritis |
Q41888326 | Vasoactive intestinal peptide generates human tolerogenic dendritic cells that induce CD4 and CD8 regulatory T cells. |
Q35849658 | Vasoactive intestinal peptide induces regulatory dendritic cells that prevent acute graft-versus-host disease while maintaining the graft-versus-tumor response |
Q38114070 | What are the molecules involved in regulatory T-cells induction by dendritic cells in cancer? |
Q33659263 | iPSC-Derived Regulatory Dendritic Cells Inhibit Allograft Rejection by Generating Alloantigen-Specific Regulatory T Cells. |
Search more.